loadpatents
Patent applications and USPTO patent grants for Flaa; Mickael.The latest application filed is for "angiogenic treatment of ischemic heart disease".
Patent | Date |
---|---|
Angiogenic Treatment Of Ischemic Heart Disease App 20210212565 - Gardner; Vance ;   et al. | 2021-07-15 |
Angiogenic treatment of ischemic heart disease Grant 10,966,610 - Gardner , et al. April 6, 2 | 2021-04-06 |
Therapeutic angiogenesis for treating erectile conditions Grant 10,433,783 - Gardner , et al. O | 2019-10-08 |
Therapeutic Angiogenesis For Treating Erectile Conditions App 20190029589 - Gardner; Vance ;   et al. | 2019-01-31 |
Therapeutic angiogenesis for treating erectile conditions Grant 9,968,292 - Gardner , et al. May 15, 2 | 2018-05-15 |
Therapeutic Angiogenesis For Wound Healing App 20170296625 - GARDNER; Vance ;   et al. | 2017-10-19 |
Angiogenic Treatment Of Ischemic Heart Disease App 20170296055 - GARDNER; Vance ;   et al. | 2017-10-19 |
SEC | 0001314768 | Flaa Mickael |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.